ESB 5070
Alternative Names: ESB-5070Latest Information Update: 28 Feb 2023
Price :
$50 *
At a glance
- Originator E-Scape Bio
- Class Antiparkinsonians; Small molecules
- Mechanism of Action LRRK2 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 28 Feb 2023 No recent reports of development identified for preclinical development in Parkinson's-disease in USA (PO)
- 14 Sep 2020 Escape Bio plans to file an IND application for prospective clinical development in Parkinson's disease
- 21 Jan 2019 E-Scape Bio plans clinical trials for Parkinson's disease in 2020